Introduction：Basic information about CAS 556743-18-1|Lumbokinase capsules, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Lumbokinase capsules |
|---|
| CAS Number | 556743-18-1 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Lumbokinase capsules BiologicalActivity
| Description | Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1]. |
|---|
| Related Catalog | Signaling Pathways >>Epigenetics >>SirtuinSignaling Pathways >>Cell Cycle/DNA Damage >>SirtuinResearch Areas >>Inflammation/Immunology |
|---|
| Target | SIRT1 |
|---|
| References | [1]. Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. Front Pharmacol. 2018 Jun 15;9:636. |
|---|
Chemical & Physical Properties
Safety Information
